利拉鲁肽是一种GLP - 1受体激动剂,这类药可在用餐后促使胰腺分泌更多的胰岛素。
Victoza is in a class of medicines known as glucagon-like peptide-1 (GLP-1) receptor agonists that help the pancreas make more insulin after eating a meal.
而VPAC1激动剂在体重、血糖、糖耐量、胰岛素浓度及内脏净重等方面的治疗效果更为明显。
VPAC1 agonist displayed more effective effects than VIP on body weight, plasma glucose, glucose tolerance, plasma insulin, the weight of viscera.
Now, sometimes the agonist is the natural ligand itself and that's - an example of that is when you use insulin as a drug.
有时激动剂药物就是天然配体分子,例如将胰岛素作为药物使用
We've identified many drugs that stimulate insulin receptors, for example, but they're not exactly insulin, and those can potentially be used as agonist type drugs.
我们已经设计了很多,能够激活胰岛素受体的药物,但它们都不是和胰岛素分毫不差的,但都可以用作激动剂类药物
应用推荐